Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazone.

about

Physiologically Based Pharmacokinetic Modeling Suggests Limited Drug-Drug Interaction Between Clopidogrel and Dasabuvir.In Vitro and In Vivo Drug-Drug Interaction Studies to Assess the Effect of Abiraterone Acetate, Abiraterone, and Metabolites of Abiraterone on CYP2C8 Activity.

P2860

Q38836056-568E8F1E-66E5-460B-8978-98CE2037C459 Q39509370-EC6903E0-004E-4F06-8013-DDEC4440920E

P2860

Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazone.

Item

http://www.wikidata.org/entity/Q50864429

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@en

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@nl

type

Item

label

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@en

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@nl

prefLabel

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@en

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@nl

P1476

Physiologically based pharmaco ...... he metabolism of pioglitazone.

@en

P2093

Jin Yang

http://www.w3.org/2001/XMLSchema#string

Liling Tang

http://www.w3.org/2001/XMLSchema#string

Qingqing Xiao

http://www.w3.org/2001/XMLSchema#string

Ruijuan Xu

http://www.w3.org/2001/XMLSchema#string

Wei Qian

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations

Prediction of CYP2D6 drug interactions from in vitro data: evidence for substrate-dependent inhibition.

Clinical pharmacokinetics and pharmacodynamics of repaglinide.

Metabolism of repaglinide by CYP2C8 and CYP3A4 in vitro: effect of fibrates and rifampicin.

The conduct of in vitro and in vivo drug-drug interaction studies: a PhRMA perspective.

Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.

A framework for assessing inter-individual variability in pharmacokinetics using virtual human populations and integrating general knowledge of physical chemistry, biology, anatomy, physiology and genetics: A tale of 'bottom-up' vs 'top-down' recogn

Physiologically based pharmacokinetics joined with in vitro-in vivo extrapolation of ADME: a marriage under the arch of systems pharmacology.

Predicting drug-drug interactions: application of physiologically based pharmacokinetic models under a systems biology approach.

Quantitative Rationalization of Gemfibrozil Drug Interactions: Consideration of Transporters-Enzyme Interplay and the Role of Circulating Metabolite Gemfibrozil 1-O-β-Glucuronide.

P304

603-612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BDD.1987

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26296069

http://www.w3.org/2001/XMLSchema#string

Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazone.

about

P2860

P2860

Physiologically based pharmacokinetics model predicts the lack of inhibition by repaglinide on the metabolism of pioglitazone.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698